ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » South Carolina » Internal Medicine

Top Internal Medicine Prescribers in South Carolina

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
SUZANNE KOVACS MD

Internal Medicine

25,708

$1.47M

951
675 are 65+

8%
patients receiving schedule two controlled substances

Avg: 5%

27%
patients receiving schedule three controlled substances

Avg: 12%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 26%

$57
Average prescription price

Avg: $62

CHARMAINE GEORGE M.D

Internal Medicine

24,374

$1.32M

488
403 are 65+

16%
patients receiving schedule two controlled substances

Avg: 5%

32%
patients receiving schedule three controlled substances

Avg: 12%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 26%

$54
Average prescription price

Avg: $62

COY EATON M.D.

Internal Medicine

24,134

$1.16M

799
532 are 65+

12%
patients receiving schedule two controlled substances

Avg: 5%

35%
patients receiving schedule three controlled substances

Avg: 12%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 26%

$48
Average prescription price

Avg: $62

VICTORIA ARLAUSKAS MD

Internal Medicine

23,715

$1.27M

960
703 are 65+

8%
patients receiving schedule two controlled substances

Avg: 5%

19%
patients receiving schedule three controlled substances

Avg: 12%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 26%

$54
Average prescription price

Avg: $62

EMMANUEL YIRENKYI MD

Internal Medicine

21,864

$957K

632
390 are 65+

2%
patients receiving schedule two controlled substances

Avg: 5%

18%
patients receiving schedule three controlled substances

Avg: 12%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 26%

$44
Average prescription price

Avg: $62

CHARLES WADEE M.D

Internal Medicine

21,317

$1.36M

645
258 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

40%
patients receiving schedule three controlled substances

Avg: 12%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 26%

$64
Average prescription price

Avg: $62

RICHARD MURRAY MD

Internal Medicine

21,296

$1.44M

626
557 are 65+

9%
patients receiving schedule two controlled substances

Avg: 5%

14%
patients receiving schedule three controlled substances

Avg: 12%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

32%
prescriptions for brand name drugs

Avg: 26%

$68
Average prescription price

Avg: $62

ALFRED EZMAN D.O.

Internal Medicine

20,563

$913K

579
471 are 65+

3%
patients receiving schedule two controlled substances

Avg: 5%

13%
patients receiving schedule three controlled substances

Avg: 12%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 26%

$44
Average prescription price

Avg: $62

DAVID LI MD

Internal Medicine

20,343

$823K

678
320 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

16%
patients receiving schedule three controlled substances

Avg: 12%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 26%

$40
Average prescription price

Avg: $62

RUSSELL BRANT MD

Internal Medicine

20,200

$1.07M

764
448 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

2%
patients receiving schedule three controlled substances

Avg: 12%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 26%

$53
Average prescription price

Avg: $62

JOSEPH WILLIAMS MD

Internal Medicine

19,770

$1.05M

634
516 are 65+

6%
patients receiving schedule two controlled substances

Avg: 5%

23%
patients receiving schedule three controlled substances

Avg: 12%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 26%

$53
Average prescription price

Avg: $62

JEFFREY CRAFT MD

Internal Medicine

19,702

$1.05M

648
487 are 65+

3%
patients receiving schedule two controlled substances

Avg: 5%

14%
patients receiving schedule three controlled substances

Avg: 12%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 26%

$53
Average prescription price

Avg: $62

ROBERT YANNETTI M.D.

Internal Medicine

19,510

$1.09M

651
475 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 12%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 26%

$56
Average prescription price

Avg: $62

GANGATHARAN MATHISUTHAN M.D

Internal Medicine

19,459

$1.04M

620
405 are 65+

8%
patients receiving schedule two controlled substances

Avg: 5%

27%
patients receiving schedule three controlled substances

Avg: 12%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 26%

$54
Average prescription price

Avg: $62

PAUL WEAVER M.D.

Internal Medicine

19,278

$876K

953
622 are 65+

4%
patients receiving schedule two controlled substances

Avg: 5%

23%
patients receiving schedule three controlled substances

Avg: 12%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 26%

$45
Average prescription price

Avg: $62

JANA MORSE M.D.

Internal Medicine

18,923

$935K

575
274 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

7%
patients receiving schedule three controlled substances

Avg: 12%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 26%

$49
Average prescription price

Avg: $62

GEORGE BASS MD

Internal Medicine

18,270

$901K

846
619 are 65+

7%
patients receiving schedule two controlled substances

Avg: 5%

25%
patients receiving schedule three controlled substances

Avg: 12%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 26%

$49
Average prescription price

Avg: $62

LLOYD MILLER MD

Internal Medicine

18,057

$1.4M

397
295 are 65+

24%
patients receiving schedule two controlled substances

Avg: 5%

5%
patients receiving schedule three controlled substances

Avg: 12%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

38%
prescriptions for brand name drugs

Avg: 26%

$78
Average prescription price

Avg: $62

ROBERT RICHEY MD

Internal Medicine

17,922

$980K

547
457 are 65+

11%
patients receiving schedule two controlled substances

Avg: 5%

23%
patients receiving schedule three controlled substances

Avg: 12%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 26%

$55
Average prescription price

Avg: $62

JAMES KELLY MD

Internal Medicine

17,842

$1.47M

501
275 are 65+

37%
patients receiving schedule two controlled substances

Avg: 5%

27%
patients receiving schedule three controlled substances

Avg: 12%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

37%
prescriptions for brand name drugs

Avg: 26%

$82
Average prescription price

Avg: $62

RICHMOND ALLAN MD

Internal Medicine

17,787

$888K

777
501 are 65+

10%
patients receiving schedule two controlled substances

Avg: 5%

30%
patients receiving schedule three controlled substances

Avg: 12%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 26%

$50
Average prescription price

Avg: $62

STUART COOPER MD

Internal Medicine

17,771

$1.23M

524
302 are 65+

8%
patients receiving schedule two controlled substances

Avg: 5%

20%
patients receiving schedule three controlled substances

Avg: 12%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 26%

$69
Average prescription price

Avg: $62

MICHAEL BLUBAUGH MD

Internal Medicine

17,724

$1.15M

460
371 are 65+

7%
patients receiving schedule two controlled substances

Avg: 5%

19%
patients receiving schedule three controlled substances

Avg: 12%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 26%

$65
Average prescription price

Avg: $62

BISMARK AMOAH-APRAKU M.D.

Internal Medicine

17,490

$977K

681
415 are 65+

4%
patients receiving schedule two controlled substances

Avg: 5%

7%
patients receiving schedule three controlled substances

Avg: 12%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 26%

$56
Average prescription price

Avg: $62

MARK DAVIS MD

Internal Medicine

17,490

$860K

667
539 are 65+

6%
patients receiving schedule two controlled substances

Avg: 5%

13%
patients receiving schedule three controlled substances

Avg: 12%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 26%

$49
Average prescription price

Avg: $62

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank